Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research focused on Multiple sclerosis and Pregnancy, with related work in Natalizumab, Tolerability, Expanded Disability Status Scale. Notable publications include 'Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder', 'Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion', and 'Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial'.
The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus
Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study
Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis
Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder
Multiple Sclerosis Progression and Relapse Activity in Children
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
Diagnosis and treatment of progressive multiple sclerosis: A position paper
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study
Natalizumab in the pediatric MS population: results of the Italian registry
An overview of pregnancy‐related issues in patients with multiple sclerosis
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study
Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study